First-Trimester Screening of Open Neural Tube Defects Using Biometrics and Maternal Serum Markers

Study acronym: BIMAS
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Open neural tube defects are congenital malformations associated with significant morbidity. Early detection during the first trimester remains a key challenge. This retrospective monocentric study aims to evaluate the diagnostic performance of fetal biometrics (biparietal diameter and abdominal transverse diameter ratios) and maternal serum markers (beta-hCG and PAPP-A) for early screening of open neural tube defects. The study will assess the predictive value of these parameters individually and in combination to define optimal screening thresholds applicable in routine clinical practice
Trial Details
NCT Number NCT07864142
Lead Sponsor University Hospital, Strasbourg, France
Conditions
(from sponsor)		 Neural Tube Defects (NTDs)
Related terms Neural Tube Defects
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov